Cancer of the pancreas is an extremely aggressive disease with a dismal prognosis. “While the overall five-year survival rate of all cancer patients stands at 63%, it is only about 5% for pancreatic cancer — a number that has remained largely unchanged for the last three decades,” notes Yasser Riazalhosseini, professor of Human Genetics at McGill and corresponding author of the new study, published in the journal Gastroenterology. Read more . . .